Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Pfizer Limited is a pharmaceutical company. The Company has a portfolio of approximately 140 products across over 15 therapeutic areas.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has increased by 2.11%
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations,2018, we furnish herewith certificate dated January 8, 2025, issued by KFin Technologies Limited, Registrar and Share Transfer Agent of the Company for the quarter ended December 31, 2024. | Download
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations,2018, we furnish herewith certificate dated January 8, 2025, issued by KFin Technologies Limited, Registrar and Share Transfer Agent of the Company for the quarter ended December 31, 2024. | Download
Final • Div/Share: ₹ 35
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant